Literature DB >> 29661471

Do the diagnostic criteria for subclinical hypercortisolism exist?

Antoine Tabarin1.   

Abstract

"Subclinical hypercortisolism" (SH) refers to a condition associated with a mild chronic increase in cortisol secretion. By definition, patients with SH do not exhibit specific symptoms of overt Cushing's syndrome (such as purple striae, easy bruising, proximal muscle weakness), SH has been preferred to "subclinical Cushing's syndrome", a semantic ambiguity since Cushing's syndrome is, by definition, a set of symptoms; and to the term "preclinical Cushing syndrome" because the progression toward overt clinical hypercortisolism is very rare. However, SH still is misnomer as a number of studies suggest that this condition may induce long-term non-specific adverse conditions related to the mild cortisol excess (i.e. diabetes, hypertension, obesity, and osteoporosis). Various attempts have been made to define SH that remains a matter of controversies and uncertainties.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Adrenal incidentaloma; Autonomie sécrétaire du cortisol; Cortisol secretory autonomy; Dexamethasone suppression test; Hypercortisolisme infraclinique; Hypercortisolisme peu intense; Incidentalome surrénalien; Mild hypercortisolism; Subclinical Cushing's syndrome; Subclinical hypercortisolism; Syndrome de Cushing infraclinique; Test de freinage par la dexaméthasone

Mesh:

Substances:

Year:  2018        PMID: 29661471     DOI: 10.1016/j.ando.2018.03.013

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  9 in total

1.  Subclinical Hypercortisolism: An Important, Unrecognized Dysfunction.

Authors:  Lara Pizzorno; Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2022-07

2.  Adrenalectomy Improves Blood Pressure and Metabolic Control in Patients With Possible Autonomous Cortisol Secretion: Results of a RCT.

Authors:  Valentina Morelli; Sofia Frigerio; Carmen Aresta; Elena Passeri; Flavia Pugliese; Massimilano Copetti; Anna Maria Barbieri; Silvia Fustinoni; Elisa Polledri; Sabrina Corbetta; Maura Arosio; Alfredo Scillitani; Iacopo Chiodini
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

Review 3.  Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.

Authors:  Barbara Altieri; Giovanna Muscogiuri; Stavroula A Paschou; Andromachi Vryonidou; Silvia Della Casa; Alfredo Pontecorvi; Martin Fassnacht; Cristina L Ronchi; John Newell-Price
Journal:  Endocrine       Date:  2018-08-02       Impact factor: 3.633

4.  Nonfunctioning Adrenal Incidentalomas: The Search for Subclinical Cardiac Alterations.

Authors:  José Luiz Barros Pena
Journal:  Arq Bras Cardiol       Date:  2018-11       Impact factor: 2.000

5.  A New Insight into the Surgical Treatment of Primary Macronodular Adrenal Hyperplasia.

Authors:  Fabio Yoshiaki Tanno; Victor Srougi; Madson Q Almeida; Fernando Ide Yamauchi; Fernando Morbeck Almeida Coelho; Mirian Yumie Nishi; Maria Claudia Nogueira Zerbini; Iracy Silvia Correa Soares; Maria Adelaide Albergaria Pereira; Helaine Laiz Silva Charchar; Amanda Meneses Ferreira Lacombe; Vania Balderrama Brondani; Miguel Srougi; Willian Carlos Nahas; Berenice B Mendonca; José Luis Chambô; Maria Candida Barisson Villares Fragoso
Journal:  J Endocr Soc       Date:  2020-07-22

6.  Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases.

Authors:  Minmin Han; Xiaoming Cao; Changjian Zhao; Luyang Yang; Nan Yin; Pengliang Shen; Jin Zhang; Fei Gao; Yi Ren; Dong Liang; Jing Yang; Yi Zhang; Yunfeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-25       Impact factor: 5.555

7.  Impact of Adrenalectomy on Morbidity in Patients with Non-Functioning Adrenal Cortical Tumours, Mild Hypercortisolism and Cushing's Syndrome as Assessed by National and Quality Registries.

Authors:  Lo Hallin Thompson; Jonas Ranstam; Martin Almquist; Erik Nordenström; Anders Bergenfelz
Journal:  World J Surg       Date:  2021-06-27       Impact factor: 3.352

Review 8.  Frequently asked questions and answers (if any) in patients with adrenal incidentaloma.

Authors:  F Ceccato; M Barbot; C Scaroni; M Boscaro
Journal:  J Endocrinol Invest       Date:  2021-06-23       Impact factor: 4.256

9.  Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.

Authors:  Tiphaine Carton; Elise Mathieu; Fleur Wolff; Jason Bouziotis; Bernard Corvilain; Natacha Driessens
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.